{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:56:46Z","timestamp":1793120206837,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajp.2021.102891","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:47:36Z","timestamp":1635173256000},"page":"102891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Selective serotonin reuptake inhibitors and manic switch: A pharmacovigilance and pharmacodynamical study"],"prefix":"10.1016","volume":"66","author":[{"given":"R. O\u011fulcan","family":"\u00c7iray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eren","family":"Hala\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Tun\u00e7t\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutlu","family":"\u00d6zbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7a\u011fatay","family":"Ermi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajp.2021.102891_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14740338.2017.1323867","article-title":"Empirical estimation of under-reporting in the US Food and Drug Administration adverse event reporting system (FAERS)","volume":"16","author":"Alatawi","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.ajp.2021.102891_bib2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2008.00613.x","article-title":"Treatment\u2010emergent mania\/hypomania in unipolar patients","volume":"10","author":"Benvenuti","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2021.102891_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jbi.2014.03.012","article-title":"Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms","volume":"49","author":"Bousquet","year":"2014","journal-title":"J. Biomed. Inform."},{"issue":"2\u20133","key":"10.1016\/j.ajp.2021.102891_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-0327(03)00194-0","article-title":"A different depression: clinical distinctions between bipolar and unipolar depression","volume":"84","author":"Bowden","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/104454603322163871","article-title":"Drug-induced disinhibition in psychiatrically hospitalized children","volume":"13","author":"Carlson","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.ajp.2021.102891_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1469-7610.2005.01467.x","article-title":"Review of the efficacy and safety of antidepressants in youth depression","volume":"46","author":"Cheung","year":"2005","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2021.102891_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.1978.01770250121012","article-title":"Physostigmine in mania","volume":"35","author":"Davis","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/104454603322163899","article-title":"Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features","volume":"13","author":"DelBello","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2021.102891_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874143600802010054","article-title":"Visualizing pharmacological activities of antidepressants: a novel approach","volume":"2","author":"Derijks","year":"2008","journal-title":"Open Pharmacol. J."},{"issue":"04","key":"10.1016\/j.ajp.2021.102891_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2002-33193","article-title":"H2-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures","volume":"35","author":"von Einsiedel","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2021.102891_bib11","unstructured":"FDA. Selective Serotonin Reuptake Inhibitors (SSRIs) Information Available: \u3008https:\/\/www.fda.gov\/drugs\/information-drug-class\/selective-serotonin-reuptake-inhibitors-ssris-information\u3009."},{"issue":"10","key":"10.1016\/j.ajp.2021.102891_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-3223(91)90170-Q","article-title":"The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group","volume":"30","author":"Gillin","year":"1991","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2021.102891_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ajp.2021.102891_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4088\/JCP.v60n0811","article-title":"Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder","volume":"60","author":"Goldstein","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib16","first-page":"136","article-title":"Mania associated with use of lurasidone in a patient with bipolar disorder","volume":"22","author":"Goyal","year":"2017","journal-title":"J. Ment. Health Hum. Behav."},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10401230590932344","article-title":"Antidepressant treatment in the primary care office: outcomes for adjustment disorder versus major depression","volume":"17","author":"Hameed","year":"2005","journal-title":"Ann. Clin. Psychiatry.: Off. J. Am. Acad. Clin. Psychiatr."},{"issue":"D1","key":"10.1016\/j.ajp.2021.102891_bib18","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkx1121","article-title":"The IUPHAR\/BPS Guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology","volume":"46","author":"Harding","year":"2018","journal-title":"Nucleic acids Res."},{"issue":"01\/02","key":"10.1016\/j.ajp.2021.102891_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2021.102891_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00004714-199612000-00003","article-title":"Induction of mania with serotonin reuptake inhibitors","volume":"16","author":"Howland","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102891_bib21","doi-asserted-by":"crossref","unstructured":"Joseph, M.F., Youngstrom, E.A., 2009. Soares Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors.","DOI":"10.2217\/14796708.4.1.87"},{"issue":"4","key":"10.1016\/j.ajp.2021.102891_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ajp.2021.102891_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002130050562","article-title":"Antidepressant-associated mania: a study of anxiety disorders patients","volume":"136","author":"Levy","year":"1998","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.ajp.2021.102891_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40264-015-0351-3","article-title":"An empirical approach to explore the relationship between measures of disproportionate reporting and relative risks from analytical studies","volume":"39","author":"Maci\u00e1-Mart\u00ednez","year":"2016","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.ajp.2021.102891_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/fcp.12201","article-title":"Mania associated with ranitidine: a case report and review of literature","volume":"30","author":"Mauran","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2021.102891_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.chi.0000242240.69678.c4","article-title":"Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder","volume":"46","author":"McClellan","year":"2007","journal-title":".J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2021.102891_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1192\/bjp.155.3.294","article-title":"The genetics of depression and manic-depressive disorder","volume":"155","author":"McGuffin","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102891_bib28","unstructured":"MedDRA, M., 2020. Introductory Guide for Standardised MedDRA Queries (SMQs) Version 23.0."},{"key":"10.1016\/j.ajp.2021.102891_bib29","unstructured":"Mukherjee, S., 2012. Post-prozac nation: the science and history of treating depression. New York Times. p. 29."},{"issue":"12","key":"10.1016\/j.ajp.2021.102891_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008341","article-title":"Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study","volume":"5","author":"Patel","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ajp.2021.102891_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/cpt1969104522","article-title":"Differential effects of scopolamine and chlorpromazine on REM and NREM sleep in normal male subiects","volume":"10","author":"Sagales","year":"1969","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.ajp.2021.102891_bib32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int. J. Med. Sci."},{"issue":"11","key":"10.1016\/j.ajp.2021.102891_bib33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4088\/JCP.09r05259gre","article-title":"The neurobiology of the switch process in bipolar disorder: a review","volume":"71","author":"Salvadore","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-5618.2000.020201.x","article-title":"Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies","volume":"2","author":"Shiah","year":"2000","journal-title":"Bipolar Disord."},{"issue":"10","key":"10.1016\/j.ajp.2021.102891_bib35","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/bcp.13699","article-title":"Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance\u2010pharmacodynamic study","volume":"84","author":"Siafis","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","article-title":"Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"72","author":"Sidor","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102891_bib37","series-title":"IBM SPSS Statistics Software Version 22","author":"Statistics IS","year":"2014"},{"issue":"6","key":"10.1016\/j.ajp.2021.102891_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0447.2009.01514.x","article-title":"Mania associated with antidepressant treatment: comprehensive meta\u2010analytic review","volume":"121","author":"Tondo","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"issue":"10","key":"10.1016\/j.ajp.2021.102891_bib39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.2014.13111501","article-title":"The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer","volume":"171","author":"Viktorin","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2021.102891_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.jcp.0000237950.65517.be","article-title":"Manic\/hypomanic switch during acute antidepressant treatment for unipolar depression","volume":"26","author":"Wada","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.ajp.2021.102891_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J. Stat. Softw."},{"issue":"4","key":"10.1016\/j.ajp.2021.102891_bib42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/dmd.108.022814","article-title":"Receptor occupancy and brain free fraction","volume":"37","author":"Watson","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ajp.2021.102891_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/104454603322163862","article-title":"A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors","volume":"13","author":"Wilens","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"D1","key":"10.1016\/j.ajp.2021.102891_bib44","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ajp.2021.102891_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570159X14666160309114549","article-title":"Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine","volume":"15","author":"Wohleb","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2021.102891_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0893-133X(97)00050-X","article-title":"Sumatriptan-induced growth hormone release in patients with major depression, mania, and normal controls","volume":"17","author":"Yatham","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ajp.2021.102891_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-0327(98)00186-4","article-title":"Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls","volume":"54","author":"Yatham","year":"1999","journal-title":"J. Affect. Disord."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821003476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821003476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:40:43Z","timestamp":1761756043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201821003476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":47,"alternative-id":["S1876201821003476"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102891","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective serotonin reuptake inhibitors and manic switch: A pharmacovigilance and pharmacodynamical study","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102891"}}